Biography and Research Information
OverviewAI-generated summary
Katelynn Callaway's research investigates the impact of different pantoprazole administration methods on the length of intensive care unit (ICU) stays for critically ill patients. Her work specifically compares continuous infusion to intravenous bolus administration. Callaway also examines changes in the purchasing patterns of intensive care medicines during the COVID-19 pandemic, comparing developed and developing countries. She has published two scholarly articles and collaborates with researchers at the University of Arkansas for Medical Sciences, including Jacob T. Painter and Allison Oswalt.
Metrics
- Publications: 2
Selected Publications
-
The Impact of Continuous Infusion Compared to Intravenous Bolus Administration of Pantoprazole on Length of Intensive Care Unit Stay in Critically Ill Patients (2021)
Collaboration Network
Top Collaborators
Mrinmayee Lakkad
University of Arkansas for Medical Sciences (US)
1 shared publication
- The Impact of Continuous Infusion Compared to Intravenous Bolus Administration of Pantoprazole on Length of Intensive Care Unit Stay in Critically Ill Patients
Jacob T. Painter
University of Arkansas for Medical Sciences
1 shared publication
In database
- The Impact of Continuous Infusion Compared to Intravenous Bolus Administration of Pantoprazole on Length of Intensive Care Unit Stay in Critically Ill Patients
Lindsey Dayer
University of Arkansas for Medical Sciences (US)
1 shared publication
- The Impact of Continuous Infusion Compared to Intravenous Bolus Administration of Pantoprazole on Length of Intensive Care Unit Stay in Critically Ill Patients
Allison Oswalt
University of Arkansas for Medical Sciences
1 shared publication
In database
- The Impact of Continuous Infusion Compared to Intravenous Bolus Administration of Pantoprazole on Length of Intensive Care Unit Stay in Critically Ill Patients
Mina Tadrous
1 shared publication
- Changes in purchases of intensive care medicines during COVID-19 in developed vs. developing countries
Sandra L. Kane‐Gill
1 shared publication
- Changes in purchases of intensive care medicines during COVID-19 in developed vs. developing countries
Ian J. Barbash
1 shared publication
- Changes in purchases of intensive care medicines during COVID-19 in developed vs. developing countries
Kazuto Suda
1 shared publication
- Changes in purchases of intensive care medicines during COVID-19 in developed vs. developing countries
Similar Researchers
Based on overlapping research topics
Ibrahim Alshaghdali
University of Arkansas for Medical Sciences
Pharmacological Effects and Toxicity Studies
Emergency and Acute Care Studies
COVID-19 Clinical Research Studies
Natalie Stirrup
University of Arkansas for Medical Sciences
Pharmacological Effects and Toxicity Studies
Emergency and Acute Care Studies
Healthcare Policy and Management
Joel Mosley
University of Arkansas for Medical Sciences
Pharmacological Effects and Toxicity Studies
Emergency and Acute Care Studies
COVID-19 Clinical Research Studies
Robert Spraggins
University of Arkansas for Medical Sciences
Pharmacological Effects and Toxicity Studies
Emergency and Acute Care Studies
COVID-19 Clinical Research Studies
J. Pagteilan
University of Arkansas for Medical Sciences
Emergency and Acute Care Studies
Healthcare Policy and Management
Health Disparities and Outcomes
Muhammad Chauhan
University of Arkansas for Medical Sciences
Emergency and Acute Care Studies
Healthcare Policy and Management
Health Disparities and Outcomes